OakChart

Agilon Health Inc

AGLHealthcare·Medical Care Facilities·USA·Small·NYSE·Nov 11 • 3:59 PM ET

114.81+1.29 (1.14%)
2026-11-12 02:30 CET
Market cap
1,928.33 USD m
Revenue, TTM
6,004.18 USD m
Net income, TTM
-106.10 USD m
Free cash flow, TTM
-18.62 USD m
EPS diluted, TTM
-6.58
P/E
-
Compare

Price

AGL against its 20, 50 and 200-day averages
2050200beat
50.00100.00558K1.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AGLclose 114.8120-day 95.4150-day 89.78200-day 68.22114.8152w high

13.7% under the 52-week high of 133.04 on 17 Jul 2026. 52-week low 7.48 on 31 Mar 2026. Last 15 sessions, 54.4% high to low

Volume 0.73× normal · the line is the 50-bar volume average

Profile

AGL
52-week range, 85% of the way up
7.48133.04

Agilon Health, Inc. engages in the provision of healthcare services. It also provides capital, data, payor relationships, executive experience, and contract support that allow physician groups to take on the risk of total care for their patients. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Westerville, OH.

IndexRUT
Employees856
IPOApr 15, 2021
Beta3.06
ATR, 14d6.76
Rel volume0.73
Short float7.22%
Insider own30.23%
Inst own73.12%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.93B
Enterprise Value1.65B
Income-106.10M
Sales6.00B
Book/sh16.72
Cash/sh18.56
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees856
IPOApr 15, 2021

Ratios

P/E-
Forward P/E39.74
PEG-
P/S0.32
P/B6.87
P/C6.19
P/FCF-
EV/EBITDA-
EV/Sales0.27
Quick Ratio1.13
Current Ratio1.13
Debt/Eq0.12
LT Debt/Eq0.07
Option/ShortYes / Yes

Earnings

EPS (ttm)-6.58
EPS next Y2.89
EPS next Q-3.39
EPS this Y98.20%
EPS next Y755.71%
EPS next 5Y-
EPS past 3/5Y-55.37% -36.60%
Sales past 3/5Y35.43% 37.24%
EPS Y/Y TTM66.99%
Sales Y/Y TTM2.02%
EPS Q/Q129.69%
Sales Q/Q5.86%
EarningsNov 04 AMC
EPS/Sales Surpr.260.16% 4.02%

Ownership

Insider Own30.23%
Insider Trans0.00%
Inst Own73.12%
Inst Trans8.35%
ROA-6.71%
ROE-36.15%
ROIC-35.45%
Gross Margin2.53%
Oper. Margin-1.66%
Profit Margin-1.77%
SMA2020.34%
SMA5027.87%
SMA20068.30%
Trades-

Technical

Shs Outstand16.80M
Shs Float11.72M
Short Float7.22%
Short Ratio3.77
Short Interest0.85M
52W High133.04 -13.70%
52W Low7.48 1434.89%
Volatility8.35% 6.27%
ATR (14)6.76
RSI (14)76.94
Beta3.06
Rel Volume0.73
Avg Volume224.54K
Volume163,553

Performance

Perf Week19.31%
Perf Month33.66%
Perf Quarter29.15%
Perf Half Y59.44%
Perf YTD566.82%
Perf Year642.27%
Perf 3Y-59.43%
Perf 5Y-81.94%
Perf 10Y-
Recom2.53
Target Price120.67
Prev Close113.52
Price114.81
Change %1.14%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 15, 2026UpgradeBBernsteinMkt Perform → Outperform$125+8.9%
Aug 11, 2026UpgradeCCitigroupSell → Neutral$115+0.2%
Jul 23, 2026DowngradeCCitigroupNeutral → Sell$105-8.5%
May 26, 2026UpgradeBBarclaysUnderweight → Equal Weight$81-29.4%
May 07, 2026UpgradeJJefferiesHold → Buy$48-58.2%
May 07, 2026UpgradeDDeutsche BankHold → Buy$49-57.3%
May 04, 2026DowngradeJJP MorganNeutral → Underweight$21-81.7%
Aug 20, 2025DowngradeBBernsteinOutperform → Mkt Perform$1.40-98.8%
Aug 06, 2025DowngradeCCitigroupBuy → Neutral$1-99.1%
Apr 25, 2025UpgradeCCitigroupNeutral → Buy$5-95.6%

Peers

Mkt cap
TickerCompanyMkt cap
ASTHAstrana Health Inc1.63B
PIIIP3 Health Partners Inc18.95M
PRVAPrivia Health Group Inc3.07B
INNVInnovAge Holding Corp1.30B
ALHCAlignment Healthcare Inc1.61B
CLOVClover Health Investments Corp2.64B
EVHEvolent Health Inc564.40M
HUMHumana Inc53.60B
CVSCVS Health Corp114.54B
UNHUnitedhealth Group Inc361.04B

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Shaker BenjaminChief Markets OfficerMar 02 '26Buy0.60500,000301,0501,367,674Mar 03 05:28 PM
Wulf John WilliamDirectorNov 12 '25Buy0.6381,00050,941365,857Jan 30 07:30 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
VXFVanguard Extended Market Index ETFAUM: 30.47B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
FYXFirst Trust Small Cap Core AlphaDEX FundAUM: 1.39B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-041.970-1.2301.9701,5191,46115
2026Q22026-08-051.0400.1441.0431,4951,45116
2026Q12026-05-062.9401.0411.7961,4201,38016
2025Q42026-02-25-11.500-7.070-11.3891,5691,46916
2025Q32025-11-04-6.750-3.735-6.6481,4351,42216
2025Q22025-08-04-6.250-2.730-6.3051,3951,47219
2025Q12025-05-060.733-0.075-0.1141,5331,50416
2024Q42025-02-25-6.500-5.423-6.4191,5221,51920
2024Q32024-11-07-7.250-2.465-7.0721,4511,47118
2024Q22024-08-06-1.750-1.758-1.8651,4831,54218
2024Q12024-05-070.250-0.318-0.3711,6041,61317
2023Q42024-02-27-10.250-6.925-11.2481,0561,03616
2023Q32023-11-02-2.000-1.358-1.9371,2161,13516
2023Q22023-08-03-1.000-0.458-1.0211,1491,10915
2023Q12023-05-091.0000.8750.9391,1361,07814
2022Q42023-03-01-3.500-2.428-3.426689.77662.017

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-4.183--5.1461,218-
2021FY-27.250-25.515-25.4291,8341,823
2022FY-6.500-5.228-6.5272,7082,683
2023FY-12.000-8.483-13.1484,3164,504
2024FY-15.250-13.888-15.2936,0616,057
2025FY-24.500-19.534-23.6345,9335,824
2026FY--0.441--5,864
2027FY-2.889--6,327
2028FY-5.086--6,989
2029FY-3.183--7,911
2030FY-5.137--8,775

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1014321,4551,4291,494
2026Q4S2026-11-0514311,4581,4291,502
2026Q4S2026-11-0414101,4561,4021,502
2026Q4S2026-10-2414201,4561,4021,502
2026Q4S2026-10-2014301,4561,4021,502
2026Q4S2026-10-0914731,4561,4021,502
2026Q4S2026-10-0214731,4561,4021,502
2026Q4S2026-09-2514731,4561,4021,502
2026Q4S2026-09-1515741,4551,4021,502
2026Q4S2026-09-1415841,4551,4021,502
2026Q4S2026-09-1115841,4551,4021,502
2026Q4S2026-08-2214741,4521,4021,502
2026Q4S2026-08-2115741,4521,4021,502
2026Q4S2026-08-1415641,4501,4021,502

Estimate history

EPS, annual-18.076-5.146-25.429-6.527-13.148-15.293-24.479-6.5766
Period2019202020212022202320242025TTM
EPS, quarterly-7.072-6.419-0.114-6.305-6.648-11.3891.7961.0431.974
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual794.4111218.3331833.5592388.224316.3636060.535932.5766004.18
Period2019202020212022202320242025TTM
Sales, quarterly1450.9321522.4861532.7821394.9821435.3211569.4911420.461494.7431519.486
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual15.63315.63316.00416.49516.25516.48816.58916.795
Period2019202020212022202320242025MRQ
Shares, quarterly16.47816.48816.52116.57116.58316.58916.60616.78516.795
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue6,004.185,932.586,060.534,316.362,388.221,833.561,218.33794.41
Cost of Goods Sold Incl. D&A5,852.076,121.196,080.154,262.742,285.811,771.691,137.71778.15
Gross Profit152.11-188.62-19.6253.63102.4161.8780.6216.26
Selling, General and Administrative Excl. Other251.70232.46264.33285.57205.32442.96137.29122.83
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-99.59-421.08-283.96-231.94-102.91-381.09-56.67-106.57
Interest Expense6.886.646.186.664.486.158.139.07
Unusual Expense54.3542.168.170.197.9312.860.000.00
Net Income Before Taxes-101.12-404.10-248.83-194.46-90.67-404.60-62.34-114.69
Income Taxes4.971.251.450.791.640.890.86-0.23
Consolidated Net Income-106.10-405.35-250.28-195.25-92.31-405.48-63.21-114.45
Net Income From Continuing Operations-106.10-405.35-250.33-195.05-92.00-405.18-63.21-114.30
Net Income-106.10-405.35-251.39-215.05-106.55-406.96-80.45-282.59
EPS (Recurring)-3.85-22.70-14.94-13.14-6.19-24.84-5.15-18.08
EPS (Basic, Before Extraordinaries)-6.43-24.48-15.29-13.15-6.53-25.43-5.15-18.08
EPS (Diluted)-6.58-24.48-15.29-13.15-6.53-25.43-5.15-18.08
EBITDA-72.23-392.48-259.49-211.78-89.14-366.42-42.57-65.16
Non-Operating Income (Expense)59.7065.7849.4844.3324.65-4.502.460.95
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense46.1938.8040.0254.7722.17213.454.883.81
Price To Sales Ratio0.230.050.131.192.765.89--
Gross Margin2.53-3.18-0.321.244.293.376.622.05
Operating Margin-1.66-7.10-4.69-5.37-4.31-20.78-4.65-13.42
Net Margin-1.77-6.83-4.15-4.98-4.46-22.20-6.60-35.57
Shares Outstanding16.8016.5916.4916.2616.5016.0015.6315.63
Market Capitalization1,928.331,928.33783.175,095.056,645.5010,802.5710,693.18-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,519.491,494.741,420.461,569.491,435.321,394.981,532.781,522.49
Cost of Goods Sold Incl. D&A1,428.241,394.471,362.231,667.131,510.401,454.731,488.941,567.23
Gross Profit91.24100.2858.23-97.64-75.08-59.7543.85-44.75
Selling, General and Administrative Excl. Other63.9580.8748.1258.7652.1156.1665.4359.91
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income27.2919.4110.11-156.40-127.18-115.91-21.59-104.66
Interest Expense1.741.611.811.721.841.571.511.57
Unusual Expense3.187.646.1137.424.090.120.533.44
Net Income Before Taxes38.9117.5829.94-187.56-110.54-104.31-1.69-104.67
Income Taxes4.00-0.380.031.32-0.330.060.201.76
Consolidated Net Income34.9117.9629.92-188.88-110.21-104.37-1.89-106.43
Net Income From Continuing Operations34.9117.9629.92-188.88-110.21-104.37-1.89-106.43
Net Income34.9117.9629.92-188.88-110.21-104.37-1.89-105.79
EPS (Recurring)2.101.352.05-9.81-6.47-6.30-0.09-6.27
EPS (Basic, Before Extraordinaries)2.081.071.80-11.39-6.65-6.30-0.11-6.42
EPS (Diluted)1.971.041.80-11.39-6.65-6.30-0.11-6.42
EBITDA34.0326.2716.90-149.43-119.75-108.59-14.71-98.17
Non-Operating Income (Expense)16.557.4227.767.9822.5713.2921.935.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense14.9018.834.947.525.9212.1513.211.80
Price To Sales Ratio0.230.310.020.050.070.160.300.13
Gross Margin6.006.714.10-6.22-5.23-4.282.86-2.94
Operating Margin1.801.300.71-9.97-8.86-8.31-1.41-6.87
Net Margin2.301.202.11-12.03-7.68-7.48-0.12-6.95
Shares Outstanding16.8016.7916.6116.5916.5816.5716.5216.49
Market Capitalization1,928.331,788.17131.35285.62427.01952.851,788.39783.17

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments285.14405.60495.10887.811,054.82135.18139.15
Short Term Receivables673.791,017.04942.46492.36293.41144.5693.25
Inventories0.000.000.000.000.000.000.00
Other Current Assets137.7635.1442.5171.1018.9714.4613.12
Total Current Assets1,096.701,457.771,480.081,451.271,367.19294.20245.53
Net Property, Plant & Equipment28.9636.9540.9931.9520.9016.0418.84
Total Investments and Advances59.7961.7644.7517.356.690.000.00
Intangible Assets65.7296.9087.9020.9696.94102.01112.69
Other Assets20.1280.6087.15175.9394.5334.1225.74
Total Assets1,271.291,733.981,740.871,697.471,586.25446.36402.79
Short Term Debt Incl. Current Port. of LT Debt19.242.469.108.458.316.426.41
Accounts Payable1,057.251,149.55968.06474.78348.65256.74184.89
Other Current Liabilities-0.000.000.0051.87-0.003.688.31
Total Current Liabilities1,076.481,152.01977.16535.09356.96266.83199.61
Long Term Debt17.5841.5043.2147.5751.3070.1774.88
Provision for Risks Charges0.000.000.000.002.110.000.00
Other Liabilities50.4969.5259.4874.1984.2884.5879.33
Total Liabilities1,144.561,263.031,079.85656.86494.66421.59353.82
Non-Equity Reserves0.000.000.000.000.00309.50281.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00
Common Equity126.73470.95661.841,041.221,091.90-284.73-232.03
Total Shareholders Equity126.73470.95661.841,041.221,091.90-284.73-232.03
Accumulated Minority Interest0.000.00-0.82-0.61-0.300.000.00
Total Equity126.73470.95661.021,040.611,091.60-284.73-232.03
Total Liabilities & Stockholders Equity1,271.291,733.981,740.871,697.471,586.25446.36402.79
Book Value Per Share7.6428.5640.7163.1268.23-18.21-14.84
Tangible Book Value Per Share3.6822.6935.3161.8562.17-24.74-22.05
Full-Time Employees8561,0761,117747648552-
Price to Book Ratio6.871.665.846.129.899.48-
Return on Assets-26.98-14.41-11.35-5.60-39.87-14.89-
Return on Equity-135.64-44.20-22.91-8.63-100.40--
Return on Invested Capital-280.88-49.06-30.50-9.79-35.60--
Quick Ratio1.021.271.512.713.831.101.23
Current Ratio1.021.271.512.713.831.101.23

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-87.10-391.35-260.10-262.80-106.86-406.79-60.05-282.74
Depreciation27.3628.5924.4620.1613.7714.6714.1041.41
Other Funds (Non Cash)105.6267.5247.2796.5121.19302.21-10.91120.47
Funds from Operations45.89-295.23-188.37-146.13-71.37-93.13-59.68-137.04
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-51.73189.47130.59-10.07-59.44-55.026.4733.18
Cash from Operating Activities-5.85-105.76-57.78-156.20-130.81-148.16-53.20-103.86
Capital Expenditures-20.45-43.11-41.28-30.82-32.66-13.43-2.35-3.91
Net Assets From Acquisitions0.000.000.00-45.250.00-1.340.000.00
Sale of Fixed Assets and Businesses0.000.000.002.190.500.0026.200.00
Purchase or Sale of Investments101.03133.72194.9149.38-405.720.000.000.00
Purchase of Investments0.00-60.15-12.01-114.66-458.260.000.000.00
Sale Or Maturity of Investments101.03193.87206.91164.0452.550.000.000.00
Other Uses-1.00-2.00-13.73-19.53-6.51-82.83-3.85-1.15
Other Sources0.000.000.000.000.007.092.060.00
Cash from Investing Activities79.5988.61139.89-44.02-444.39-90.5122.07-5.06
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock4.46-2.991.17-188.1333.061,189.0327.66180.19
Repurchase of Common Pref Stock-0.02-2.990.00-200.000.000.00-6.740.00
Sale of Common Pref Stock4.470.001.1711.8733.061,189.0334.40180.19
Proceedsfrom Stock Options4.470.001.1711.8733.061,170.9433.59180.19
Issuance or Reduction of Debt, Net-3.500.00-3.75-5.00-5.00-19.90-3.04-3.59
Change in Long Term Debt-3.500.00-3.75-5.00-5.00-19.90-3.04-3.59
Issuance of Long Term Debt0.000.000.000.000.00100.000.000.00
Reduction of Long Term Debt-3.500.00-3.75-5.00-5.00-119.90-3.04-3.59
Net Financing Active Other Cash Flow0.000.000.000.000.00-14.740.00-0.30
Other Financing Activities Uses0.000.000.000.000.00-14.740.00-0.30
Cash from Financing Activities0.95-2.99-2.58-193.1328.061,154.3924.62176.30
Net Change in Cash74.69-20.1579.53-393.35-547.14915.73-6.5267.38
Free Cash Flow-18.62-119.00-71.03-172.03-146.23-154.72-54.98-106.75
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.53-3.23-2.81-16.18

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments311.74257.25302.99285.14310.85327.00
Short Term Receivables1,017.121,059.79899.75673.79947.161,047.16
Inventories0.000.000.000.000.000.00
Other Current Assets70.93101.49118.44137.7680.0278.50
Total Current Assets1,399.791,418.531,321.171,096.701,338.031,452.66
Net Property, Plant & Equipment28.4829.3930.1328.9630.0836.25
Total Investments and Advances63.9765.0872.1559.7990.4777.91
Intangible Assets56.8560.1362.4565.7299.3989.73
Other Assets16.4318.2019.0420.1238.2856.35
Total Assets1,565.521,591.341,504.941,271.291,596.241,712.89
Short Term Debt Incl. Current Port. of LT Debt15.0214.9114.7519.2434.9734.95
Accounts Payable1,218.301,297.431,257.581,057.251,204.911,214.14
Other Current Liabilities-0.00-0.000.00-0.000.00-0.00
Total Current Liabilities1,233.321,312.351,272.331,076.481,239.881,249.09
Long Term Debt18.4018.5318.6517.582.156.43
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities32.9232.9332.5350.4948.1348.45
Total Liabilities1,284.641,363.811,323.511,144.561,290.171,303.97
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity280.88227.53181.43126.73306.08408.93
Total Shareholders Equity280.88227.53181.43126.73306.08408.93
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity280.88227.53181.43126.73306.08408.93
Total Liabilities & Stockholders Equity1,565.521,591.341,504.941,271.291,596.241,712.89
Book Value Per Share16.7213.5610.937.6418.4624.68
Tangible Book Value Per Share13.349.977.173.6812.4619.26
Full-Time Employees---856--
Price to Book Ratio6.879.810.722.251.402.33
Return on Assets-6.71-15.21-21.73-26.98-17.51-16.98
Return on Equity-36.15-78.94-109.59-135.64-73.31-60.64
Return on Invested Capital11.677.3014.95-130.89-35.75-25.13
Quick Ratio1.131.081.041.021.081.16
Current Ratio1.131.081.041.021.081.16

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income34.9117.9648.92-188.88-110.21-104.37
Depreciation6.746.866.796.977.437.32
Other Funds (Non Cash)20.2031.87-25.1678.71-8.109.09
Funds from Operations61.8556.6930.54-103.20-110.88-87.96
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-11.98-113.99-8.4382.6792.7252.88
Cash from Operating Activities49.87-57.3022.12-20.54-18.15-35.09
Capital Expenditures-3.26-4.31-3.13-9.76-16.53-5.93
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments21.0824.2222.4033.3435.1977.39
Purchase of Investments0.000.000.000.000.00-12.64
Sale Or Maturity of Investments21.0824.2222.4033.3435.1990.03
Other Uses0.000.000.00-1.000.00-1.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities17.8219.9119.2722.5818.6670.46
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.124.63-0.04-0.02-0.24-2.58
Repurchase of Common Pref Stock0.000.04-0.04-0.02-0.24-2.58
Sale of Common Pref Stock-0.124.600.000.000.000.00
Proceedsfrom Stock Options-0.124.600.000.000.000.00
Issuance or Reduction of Debt, Net0.000.00-3.500.000.000.00
Change in Long Term Debt0.000.00-3.500.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.00-3.500.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.124.63-3.54-0.02-0.24-2.58
Net Change in Cash67.57-32.7637.852.030.2732.79
Free Cash Flow46.62-60.7419.02-23.50-21.33-38.34

Revenue breakdown

Medical Services2024: 6.05B 2025: 5.92B
Other Operating2024: 12.82M 2025: 11.24M
United States2024: 6.06B 2025: 5.93B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.22%0.8M11.7M254.05K
2026-10-157.67%0.9M11.7M281.35K
2026-09-308.61%1.0M11.7M294.85K
2026-09-158.96%1.1M11.7M314.96K
2026-08-319.25%1.1M11.7M328.38K
2026-08-148.38%1.0M11.7M343.30K
2026-07-317.40%0.9M11.8M396.18K
2026-07-157.34%0.9M11.7M415.17K
2026-06-306.18%0.7M11.7M441.02K
2026-06-155.53%0.6M11.7M403.42K
2026-05-295.40%0.6M11.7M395.83K
2026-05-155.46%0.6M11.7M394.88K
2026-04-306.59%0.8M12.0M330.60K
2026-04-158.35%1.0M12.0M297.13K
2026-03-318.31%1.4M16.3M270.84K
2026-03-136.53%1.1M16.3M275.67K
2026-02-276.02%1.0M16.3M296.31K
2026-02-135.00%0.8M16.3M330.86K
2026-01-306.63%0.8M12.2M356.28K
2026-01-156.71%0.8M12.2M357.33K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call40.0073.1076.300.004.7780.000.000.977-0.2300.010
call45.0068.6071.400.004.3540.000.000.978-0.1840.009
call50.0063.1066.500.003.9750.000.000.971-0.2250.012
call55.0058.7061.000.003.3090.000.000.967-0.2220.013
call60.0053.1056.600.003.2630.000.000.963-0.2190.014
call65.0048.1051.700.002.9680.000.000.966-0.1750.013
call70.0043.1046.3049.502.4975.000.000.954-0.2100.017
call75.0038.7041.2040.002.1764.000.000.948-0.2050.019
call80.0033.9036.0040.001.83913.000.000.941-0.1980.021
call85.0028.8031.5029.911.75523.000.000.933-0.1910.023
call90.0023.9026.307.501.44951.000.000.922-0.1830.026
call95.0019.1021.5024.731.2621010.000.897-0.1930.032
call10014.5016.9012.701.1081100.000.816-0.2990.047
call10510.1012.609.800.98223.000.000.769-0.2680.054
call1106.709.006.300.91895.000.000.641-0.3570.067
call1154.406.703.000.9647.000.000.524-0.4120.071
call1202.454.306.500.91110.000.000.406-0.3710.069
call1250.804.101.271.11224.000.000.339-0.4120.065
call1300.003.204.001.0886.000.000.256-0.3560.057
call1350.002.851.201.2779.000.000.235-0.3990.055
call1400.003.802.551.4337.000.000.217-0.4270.052
call1450.002.550.001.3410.000.000.154-0.3220.042
call1500.002.500.001.4150.000.000.134-0.3090.038
put40.000.002.150.003.8880.000.00-0.020-0.1930.009
put45.000.002.200.353.4311.000.00-0.022-0.1790.009
put50.000.001.350.503.2623.000.00-0.029-0.2200.012
put55.000.002.250.702.9293.000.00-0.033-0.2160.013
put60.000.002.251.802.62520.000.00-0.037-0.2120.014
put65.000.001.351.502.34552.000.00-0.041-0.2070.016
put70.000.001.350.752.08495.000.00-0.046-0.2020.017
put75.000.002.350.501.83981.000.00-0.052-0.1960.019
put80.000.000.900.101.60840.0010.00-0.059-0.1900.021
put85.000.102.605.001.3882130.00-0.067-0.1820.023
put90.000.100.800.291.09438.000.00-0.066-0.1400.023
put95.000.100.950.501.01929.0010.00-0.103-0.1830.032
put1000.002.354.151.0803.000.00-0.184-0.2880.047
put1051.102.101.950.834156105-0.231-0.2560.054
put1102.004.404.700.9305.000.00-0.359-0.3440.067
put1154.507.707.001.06077.000.00-0.476-0.3990.071
put1207.6010.308.001.0104.000.00-0.594-0.3580.069
put12511.2013.509.000.9712.000.00-0.661-0.3980.065
put13015.0017.4012.000.9715.000.00-0.726-0.3800.059
put13519.6021.9052.901.0301.000.00-0.765-0.3840.055
put14024.4026.7051.001.1261.000.00-0.783-0.4110.052
put14529.4031.900.001.3070.000.00-0.857-0.2800.040
put15034.0037.200.001.5070.000.00-0.823-0.4150.046

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-16SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-11SCHEDULE 13G/ASEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-07-228-KCurrent report2026-07-17SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-02SEC
2026-06-038-KCurrent report2026-06-02SEC
2026-05-274Statement of changes in beneficial ownership of securities2026-05-24SEC
2026-05-14SCHEDULE 13GSEC
2026-05-13SCHEDULE 13GSEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-113Initial statement of beneficial ownership of securities2026-05-07SEC
2026-05-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-04-27DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-278-KCurrent report2026-04-24SEC
2026-04-23ARSAnnual report to security holders. 2025-12-31SEC
2026-04-23DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-22DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-02SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-03301.05K100
2026-020000
2026-010000
2025-120000
2025-1150.94K100

Institutional holders

Manager% owned
Clayton, Dubilier & Rice, LLC23.98%
MORGAN STANLEY12.05%
North Peak Capital Management, LLC8.90%
BlackRock, Inc.6.87%
AQR CAPITAL MANAGEMENT LLC4.15%
GOLDMAN SACHS GROUP INC4.12%
VANGUARD CAPITAL MANAGEMENT LLC3.15%
MARSHALL WACE, LLP2.81%
Durable Capital Partners LP2.64%
D. E. Shaw & Co., Inc.2.34%

Funds

Fund% owned
AVIP Constellation Dynamic Risk Balanced Portfolio47.95%
Morningstar Total Return Bond Fund16.78%
BlackRock Advantage International Fund13.03%
AVIP Bond Portfolio11.99%
Empower Core Bond Fund9.74%
Alternative Access First Priority CLO Bond ETF5.99%
Avantis International Equity ETF5.05%
Empower Core Strategies: Flexible Bond Fund3.90%
Empower U.S. Government Securities Fund3.30%
MEDIUM-DURATION BOND FUND3.21%

OakChart. AGL. Cached 15 minutes.